FDC gets EIR from USFDA for Roha manufacturing facility

15 Jun 2023 Evaluate

FDC has received Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for manufacturing facility located at, 19 & 20/2 Plot, MIDC Industrial Area, Dhatav, Roha, Raigad District, Maharashtra, India. 

USFDA had conducted an inspection at said manufacturing facility from March 20, 2023 to March 24, 2023. FDA has determined that the inspection classification of this facility is ‘no action indicated’ (NAI). Based on this inspection, this facility is considered to be in an acceptable state of compliance with regards to current good manufacturing practice (CGMP). 

FDC made a modest beginning with marketing of vitamins and a range of prescription formulations. The company subsequently set up their formulations manufacturing facility and also pioneered the manufacture of specialized ophthalmic formulations in India.


FDC Share Price

398.95 -12.45 (-3.03%)
04-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1709.40
Dr. Reddys Lab 1109.75
Cipla 1415.55
Lupin 1971.10
Zydus Lifesciences 866.65
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...